会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • NOVEL 1'alpha'-HYDROXY VITAMIN D4 AND NOVEL INTERMEDIATES AND ANALOGUES
    • 新型1α-羟基维生素D4和新型中间体和类似物
    • WO1992005130A1
    • 1992-04-02
    • PCT/US1991006865
    • 1991-09-20
    • LUNAR CORPORATIONKNUTSON, Joyce, C.BISHOP, Charles, W.MORIARTY, Robert, M.
    • LUNAR CORPORATION
    • C07C09/00
    • A61K31/592C07C35/21C07C401/00
    • Novel 1 alpha -hydroxy vitamin D4 and novel analogues, 1,25 dihydroxy vitamin D4 and 1,24 dihydroxy vitamin D4 which are useful as active compounds of pharmaceutical compositions for the treatment of disorders of calcium metabolism. Preparation of the novel 1 alpha -hydroxy vitamin D4 starts from ergosterol which is converted in six steps to 22,23-dihydroergosterol. 22,23-dihydroergosterol was irradiated to yield vitamin D4 which is converted in four steps to 1 alpha -hydroxy vitamin D4 using a cyclovitamin procedure which produces the novel intermediates, vitamin D4 tosylate, 3,5 cyclovitamin D4 and 1 alpha -hydroxy cyclovitamin D4. 1,25 dihydroxy vitamin D4 and 1,24 dihydroxy vitamin D4 are isolated as biological products of the metabolism of novel 1 alpha -hydroxy vitamin D4 using cultured human liver cells.
    • 新型1α-羟基维生素D4和新型类似物,1,25二羟基维生素D4和1,24二羟基维生素D4,其可用作治疗钙代谢紊乱的药物组合物的活性化合物。 新型1α-羟基维生素D4的制备从麦角甾醇开始,其被六步转化为22,23-二氢麦角甾醇。 22,23-二氢麦角甾醇被照射以产生维生素D4,其使用环维生素方法四步转化为1α-羟基维生素D4,其产生新的中间体维生素D4甲苯磺酸酯,3,5环维生素D4和1α-羟基环维生素D4 。 使用培养的人肝细胞分离1,25二羟基维生素D4和1,24二羟基维生素D4作为新型1α-羟基维生素D4的代谢的生物产物。
    • 8. 发明申请
    • ULTRASONIC DENSITOMETER DEVICE AND METHOD
    • 超声波传感器装置及方法
    • WO1993025146A1
    • 1993-12-23
    • PCT/US1993005437
    • 1993-06-08
    • LUNAR CORPORATION
    • LUNAR CORPORATIONWIENER, Scott, A.DELUHERY, James, G.
    • A61B08/08
    • A61B8/4281A61B8/0875G01N29/07G01N29/11G01N29/28G01N29/348G01N2291/011G01N2291/015G01N2291/02483G01N2291/106
    • An ultrasound densitometer (100) is disclosed in which ultrasonic transducers (121) are located spaced apart in a water bath (103) into which the heel of a person may be inserted. The transit time of an ultrasonic pulse through the water and heel the attenuation of the pulse may be measured to evaluate the physical properties of the bone in the heel. A central controller (38, 160, 162) coordinates the ultrasonic measurement with the automatic filling and draining of the water bath to ensure hygienic and repeatable operation. The water may be preheated to reduce patient discomfort and to improve the consistency of the result. The delay of preheating is reduced by preheating water in a separate pre-fill chamber (132) during the previous scan. Gravity feed of the water reduces the complexity of the water handling and provides extremely quiet operation. A toe peg (110) in the water bath, which fits between the patient's toes, and a calf support (120) help to reduce patient motion during the measuring.
    • 公开了一种超声波密度计(100),其中超声波换能器(121)位于水浴(103)中间隔开的位置,可以插入人的脚跟。 可以测量超声波脉冲穿过水和脚跟的脉冲的衰减的传播时间,以评估脚后跟骨的物理性质。 中央控制器(38,160,162)通过水浴的自动灌装和排水来协调超声波测量,以确保卫生和可重复的操作。 可以预热水以减少患者的不适,并提高结果的一致性。 在先前的扫描期间,通过在单独的预填充室(132)中预热水来减少预热的延迟。 水的重力进料降低了水处理的复杂性,并提供了非常安静的操作。 位于患者脚趾之间的水浴中的脚趾钉(110)和小腿支撑件(120)有助于在测量期间减少患者运动。